[ad_1]
Donald Trump continues his “battle” with the coronavirus, having as an “ally” the treatment created and improved by Regeneron Pharmaceuticals, led by a Greek scientist, George Gankopoulos.
The Greek scientist and his collaborator, Christos Kyratsous, who is involved in research for the specific treatment with monoclonal antibodies, claimed that the specific treatment was not approved and there was a foot race to get the “green light” from the FDA.
As Kyratsous said, speaking to ANT1, the drug has been administered to 2,000 people so far and has immediate effects against the coronavirus.
In fact, as you said, 99% of the viral load drops within the first week. This applies even to the elderly and underlying diseases.
He stressed that there were no side effects during the trial, which is why Trump’s associates chose this treatment.
“I would give it to myself”
The antibody cocktail created by the company manages to reduce the mutation of the virus and at the same time immediately reduces the treatment time.
“Scientists have isolated three types to find the ones that adhere best to the virus. They chose two because they found that they clung to slightly different spots on the pins.” So if the virus mutates and its structure changes, at least one antibody will continue to work. “reported the BBC.
“They asked us to provide it to him and this was done under the supervision of the US health agency, and as we all heard, he turned it over to the president and we hope it will help him recover quickly and come back healthy,” said the co-founder and President of REGENEROR George Gankopoulos.
“I would give myself this drug if I was infected with COVID-19, and I would give it to my loved ones, and that is a kind of limit that we have set on whether we really believe it has the potential to be effective,” he added. George Giankopoulos.
[ad_2]
